FILING ANALYSIS · TUESDAY, NOVEMBER 10
INTELLIGENT BIO SOLUTIONS INC. INBS — 8-K: Results of Operations and Financial Condition
positive
The company reported record quarterly revenue of $1.39 million, a 25% year-over-year increase, and a gross profit margin of 54.5%, driven by higher-margin cartridge sales, and also submitted its FDA 510(k) premarket notification, a key step toward U.S. market entry
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →